Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
Krystal Biotech will join the 2026 Cantor Global Healthcare Conference with a webcasted fireside chat and investor meetings on September 10.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Krystal Biotech (KRYS) will participate in the 2026 Cantor Global Healthcare Conference on September 10, 2026, in New York.
Management is scheduled for a fireside chat at 3:55 p.m. ET and will also host investor meetings during the day. A webcast of the presentation will be available starting at 3:55 p.m. ET and posted in the Investors section of the company’s website.
Details
News Market Reaction – KRYS
On Sep 3, the day this news came out, KRYS closed 0.61% above the previous close. Our momentum scanner recorded 17 alerts in the available session data. Relative volume reached 2.4x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Conference date
- September 10, 2026
- 2026 Cantor Global Healthcare Conference
- Fireside chat time
- 3:55 pm ET
- September 10, 2026
- Announcement date
- September 03, 2026
- Company announcement dateline
Historical Context
-
Quarterly revenue growth, profitability, cash balance, and full-year expense guidance
-
Company scheduled second-quarter results and an 8:30 a.m. ET conference call
-
Krystal was scheduled to join the S&P MidCap 400 effective July 24
-
UK MHRA marketing authorization for VYJUVEK in dystrophic epidermolysis bullosa
-
Company announced a BofA healthcare conference fireside chat and investor meetings
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PITTSBURGH, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 2026 Cantor Global Healthcare Conference on September 10, 2026, in New York. Management will take part in a fireside chat scheduled at 3:55 pm ET and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 3:55 pm ET on Thursday, September 10, 2026 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. Visit www.krystalbio.com to learn more or follow us on LinkedIn and X.
CONTACT
Investors and Media:
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.